Showing 1 - 20 results of 52 for search '"MD5"', query time: 0.08s Refine Results
  1. 1

    Characterization of Md5-BAC-REV-LTR virus as Marek’s disease vaccine in commercial meat-type chickens: protection and immunosuppression by C., Ellington, A. L., Cortes, Nik Mohd Azmi, Nik Mohd Faiz, J. K., Mays, Fadly, Aly, Silva, Robert F., I. M., Gimeno

    Published 2021
    “…Md5-BAC-REV-LTR is a recombinant Marek’s disease virus (MDV), with an insertion of the long terminal repeat (LTR) of reticuloendotheliosis virus (REV) into the genome of the highly virulent MDV strain rMd5. …”
    Article
  2. 2

    WBEC: A web browsers evidence collection toolkit for web browsers usage in Windows 10 by Rayman, Dafiqah Mior, Asmawi, Aziah, Mohd Ariffin, Noor Afiza

    Published 2022
    “…In addition, the SHA-1 hashing method is more secure than MD5 since it takes longer to crack.…”
    Article
  3. 3

    Evaluation of factors influencing the development of late Marek`s disease virus-induced immunosuppression: virus pathotype and host sex by Nik Mohd Azmi, Nik Mohd Faiz, Cortes, Aneg L., Guy, James S., Fletcher, Oscar J., Cimino, Thomas, Gimeno, Isabel M.

    Published 2017
    “…Five MDV strains representing three different pathotypes: virulent (vMDV; 617A, GA), very virulent (vvMDV; Md5), and very virulent plus (vv+MDV; 648A, 686), were evaluated. …”
    Get full text
    Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Identification of antifungal peptides produced by Lactobacillus plantarum IS10 grown in the MRS broth by Muhialdin, Belal J., Hassan, Zaiton, Abu Bakar, Fatimah, Saari, Nazamid

    Published 2016
    “…In this study, the cell free supernatant containing peptides obtained from Lactobacillus plantarum IS10 was fractionated by size exclusion chromatography using sephadex G-25, and tested against Aspergillus flavus MD3, Penicillium roqueforti MD4 and Eurotium rubrum MD5. Among the fractions, fraction number 10 showed 60% antifungal activity at a concentration of 0.02 mg peptide/mL. …”
    Get full text
    Article
  19. 19

    Systematic review and meta-analysis of the efficacy and safety of oseltamivir (Tamiflu) in the treatment of Coronavirus Disease 2019 (COVID-19) by Aliyu, Basiru, Raji, Yakubu Egigogo, Chee, Hui Yee, Wong, Mui Yun, Sekawi, Zamberi

    Published 2022
    “…The duration of hospitalisation was significantly shorter in the oseltamivir group following sensitivity analysis (MD -5.95, 95% CI -9.91--1.99 p = 0.003, heterogeneity I2 0%, p = 0.37). …”
    Article
  20. 20